Both in Pharmaceuticals
Kiniksa Pharmaceuticals International vs Rhythm Pharmaceuticals
Over the past year KNSA returned +149.5% and RYTM returned −25.8%; their daily moves had a correlation of 0.27.
KNSA +149.5% RYTM −25.8%Growth of $1, one year, split-adjusted
| Metric | KNSA | RYTM |
|---|---|---|
| Price | $93.47 | $84.43 |
| Market cap | $7.34B | $5.81B |
| Today | +2.94% | −9.64% |
| 1 month | +22.5% | −8.7% |
| 6 months | +64.7% | −8.5% |
| Year to date | +126.6% | −21.1% |
| 1 year | +152.6% | −25.8% |
| Revenue growth (YoY) | +58.1% | +46.9% |
| Gross margin | 90.3% | 87.5% |
| Net margin | 16.6% | −70.7% |
| P/E (TTM) | 67.0× | — |
| Price / sales | 7.8× | 24.2× |
| Net cash | $462.9M | $224.8M |
| Dividend yield | — | — |
| Volatility (60d) | 54.0% | 36.8% |
| Short % of float | 9.6% | 17.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).